Tirzepatide acts on GLP-1 and another hormone called GIP, which may give stronger appetite control and weight-loss effects for some people
Research has documented BPC-157s effects on wound healing, tendon and ligament repair, bone healing, protection of the GI tract, blood vessel formation, anti-inflammatory activity, and even neuroprotective properties
Some people prefer the simplicity of a daily tablet
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: The SURMOUNT-3 phase 3 trial
While compounded semaglutide was temporarily allowed during drug shortages, it must be phased out by April or May 2025, depending on the facility type
PeptiLab products are not approved by Health Canada or the FDA for human use